Sinusoidal Vision Technology

Sinusoidal Vision Technology
Colin Kerr
Colin Kerr
Published: Friday, December 13, 2019
VSY Techanology has announced that Acriva Trinova has been registered by the European Patent Office. "In 2018, VSY Biotechnology introduced its next generation Sinusoidal Vision Technology by developing its conventional optical structure," said a company spokesperson. "An intraocular lens produced with SVT, AcrivaUD Trinova’s Sinusoidal trifocal optic design has been officially registered by the European Patent Office," said the spokesperson. According to VSY, Acriva Trinova is the next-generation trifocal IOL designed with stepless zones as opposed to stepped zones found in the optics of conventional trifocal intraocular lenses. Twelve unique ridges on the optic surface create the highest light transmission, widest depth of focus and optimum light distribution through all pupil diameters. "Moreover, Ultra Definition (UD) aspheric optic, chromatic aberration-free structure and widest depth of focus promise a spectacle independence life at all distances", say VSY
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...